Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Christophe Jean

At a glance: Christophe Jean is Director at Rhythm Pharmaceuticals (RYTM). Their latest SEC Form 4, filed Nov 18, 2026, reported a sale of $534K. On file: 0 purchase lines ($0) and 3 sale lines ($1.1M).

Disclosed holdings: about $1.4M of RYTM stock: 11,712 shares reported on their latest Form 4 (filed Nov 18, 2026), valued at the Nov 19, 2026 close of $116.97. This counts only RYTM shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Rhythm Pharmaceuticals, Inc. (RYTM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M

Christophe Jean's InsiderPrint

3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Christophe Jean: 3 trades, 2026 to 20262026: 0 buys, 3 sales

Reading this print: Almost only sells, trading about 3 times a year, typically $288K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (3)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Chris SteddumCFO · TPL · 100% match
  2. John D. Longley Jr.COO, President · OMEX · 100% match
  3. Jeffrey R. KlinglerCOO · WS · 100% match
  4. Jeremy CoxCTO · HPE · 100% match
  5. Lizette Benedi HerraizGeneral Counsel · STRA · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 18SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 5,00016,712 held (−23%) $106.81 $534K +9.5%
Nov 18SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,50014,212 held (−15%) $110.00 $275K +6.3%
Nov 18SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,50011,712 held (−18%) $115.00 $288K +1.7%
  • Sell

    Director Christophe Jean sold $534K of RYTM at $106.81 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Christophe Jean sold $275K of RYTM at $110.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Christophe Jean sold $288K of RYTM at $115.00 — pre-scheduled 10b5-1 plan sale.

Follow Christophe Jean

Get one email when Christophe Jean files a new purchase or sale. Free.

At most one email a day about Christophe Jean, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.